Company / Cash per Share
Ensysce Biosciences, Inc. Cash per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$3.18
FY2025
5-year range
$2.10 / $16.70
FY2022-FY2025
Trend
-81.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $2.10 to $3.18 over the past 2 years.
Based on SEC 10-K filings.
3.18 in FY2025 with a 3-year CAGR of -32.0%.
Improved from $2.10 to $3.18 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -32.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 81.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.18 | -81.0% |
| FY2024 | $16.70 | +694.3% |
| FY2023 | $2.10 | -79.2% |
| FY2022 | $10.12 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026